Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions has pathways that are regulated by condensates or arise from the dysfunction of condensates - including cancer, neurodegeneration, and metabolic disease.

Biotechnology

Education

Dewpoint Therapeutics

Ameet Nathwani

Kathleen Serbe

Michael Wagner

Étienne Dumoulin

Suguna Rachakonda

Stephanie Robertson

Thomas Durand-Réville

Nino Jeena

Dean Mula

Geoff Stamper

Isaac Klein

Lori Escobedo

Elina Sinisalo

Aravind Subramanian

Kelly Clark

Michael Fenn

Science and Research

Advisory Team

Leadership Team

Board of Directors

Accounting and Finance

Project Management and Strategy Team

Lab Operations

Teams at Dewpoint Therapeutics